Research by Benjamin Sanchez Terrones, Ph.D., and Benjamin Steinberg, M.D., suggests that some wearable smart devices could interfere with cardiac implantable electronic devices such as pacemakers and ...
St. Francis has been recognized nationally for its leadership in clinical excellence and research integrity, earning a Tier 1 Scholarship.
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
The 2025 Appropriate Use Criteria for implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT), and pacing have been released. This year’s guideline is broader than ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...
Today, the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Latin American Heart Rhythm Society (LAHRS) released a new clinical practice guideline on cardiac physiologic ...
LISBON, Portugal—Patients who undergo a cardiac prehabilitation prior to elective surgery or procedures via a smartphone app have a lower incidence of major adverse cardiovascular events (MACE) ...
Zacks Investment Research on MSN
ISRG's da Vinci gains FDA nod for cardiac surgery: TAM growth ahead?
Intuitive Surgical ISRG is positioning cardiac surgery as a long-term growth lever for the da Vinci 5 platform following recent regulatory progress. The company recently received FDA clearance for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results